HONOLULU (HawaiiNewsNow) - The University of Hawaii is working to develop a vaccine aimed at protecting humans against the Ebola virus, officials announced Wednesday.
UH Manoa, the John A. Burns School of Medicine and Hawaii Biotech Inc. have agreed to partner in the clinical development of the Filovirus vaccine based upon promising results from testing on animals. Currently, there are no licensed vaccines available for humans.
The Filovirus vaccine was originally developed by Dr. Axel Lehrer -- who worked with HBI and UH Manoa – and other HBI researchers. While the initial vaccine for humans is designed to protect against the Ebola virus alone, researchers are also formulating another vaccine that will protect against two other closely related filoviruses: the Sudan virus and the Marburg virus.
Ebola vaccine candidates have yet to demonstrate safety and efficacy in humans to gain regulatory approval. Development of this vaccine is in response to the current Ebola outbreak in West Africa that killed more than 10,000.